Clinical Trials Browser

Phase 2 × INDUSTRY × E7777 fusion protein × Clear all

NCT02676778 2021-07-15

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Phase 2 Completed

45 enrolled 28 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral